SYNERCOMB Trademark
SYNERCOMB is a USPTO trademark filed by VIATRIS GmbH & Co. KG. Status: Abandoned.
Trademark Facts
| Mark | SYNERCOMB |
|---|---|
| Serial Number | 76420146 |
| Status | Abandoned |
| Filing Date | 2002-06-03 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | VIATRIS GmbH & Co. KG |
| Attorney of Record | Mr. Scott D. Woldow |
| Prosecution Events | 21 |
| Latest Event | TCCA on 2013-05-30 |
Goods & Services
Pharmaceutical preparations for the treatment of disorders and diseases of the respiratory system, gastrointestinal system, endocrine system, cardiovascular system, nervous system, musculoskeletal system, urinary system, integumentary system and reproductive system, pharmaceutical preparations for the treatment of blood diseases and disorders; dermatologic pharmaceutical preparations; antimycotic pharmaceutical preparations; hormone therapy preparations; medical diagnostic reagents; pharmaceutical preparations for the treatment of colds, coughs and influenza; pharmaceutical preparations for ophthalmic use;pharmaceutical preparations for treating dandruff; laxatives; analgesics,antipyretics, antispasmodics; oral contraceptives, antiseptics, pharmaceutical preparations for the treatment of hypo tension, pharmaceutical preparations for the treatment of hypertension, pharmaceutical preparations for the treatment of obesity; antiallergic pharmaceutical preparations; pharmaceutical preparations for the treatment of gout; anti-inflammatory pharmaceuticals; antibiotics, antineoplastics, pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations of asthma; pharmaceutical preparations of mouth and gum disease; pharmaceutical preparations for the treatment of vertigo pharmaceutical preparations for the treatment of nausea; pharmaceutical preparations for the treatment of migraines; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for treating AIDS and related symptoms; vitamin preparations; mineral additive dietary supplements; vaccines; X-ray contrast agents